Evercore ISI analyst Elizabeth Anderson lowered the firm’s price target on Rite Aid (RAD) to $0 from $1 and keeps an Underperform rating on the shares ahead of Q3 earnings from the healthcare tech and distribution group. In the group, the firm’s top picks include CVS Health (CVS), its top large cap pick, Iqvia (IQV) and R1 RCM (RCM), the analyst tells investors.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on RAD:
- Unusually active option classes on open October 11th
- Largest borrow rate increases among liquid names
- Rite Aid receives noncompliance notification from Nasdaq
- Novavax Stock (NASDAQ:NVAX) Surged After Winning the FDA’s Approval
- Unusually active option classes on open October 3rd
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue